Hematologic side effects of psychotropics (Q33729895)

29 July 2017

1 reference

title

Hematologic side effects of psychotropics (English)

1 reference

29 July 2017

Oyesanmi O

1

1 reference

29 July 2017

Kunkel EJ

series ordinal

2

1 reference

29 July 2017

Monti DA

series ordinal

3

1 reference

29 July 2017

Field HL

series ordinal

4

1 reference

29 July 2017

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

40

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

414-421

1 reference

Drug-induced immune thrombocytopenia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Hematologic side effects of psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Leukocyte regulation in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Timing and risk of bone marrow depression by psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

A review of cyclic antidepressant-induced blood dyscrasias

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Drug-induced leukopenia and aplastic anemia

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Mechanisms of clozapine-induced agranulocytosis

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Eosinophilia after Commencement of Clozapine Treatment

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Tricyclic antidepressant agranulocytosis

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Selective Serotonin Reuptake Inhibitors: Infrequent Medical Adverse Effects

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Bruising associated with the use of fluoxetine

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Psychopharmacologic treatment of depression in the medically ill

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Lithium carbonate and granulocyte production: dose optimization

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levels

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Lithium inhibition of ristocetin-induced fibrinogen precipitation

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Increase in white blood cell count and serum sodium level following the addition of lithium to carbamazepine treatment among three chronically psychotic male patients with disturbed affective states.

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Changes in red blood cells with valproate therapy.

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Acute Treatment of Bipolar Depression with Gabapentin

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Human Safety of Lamotrigine

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(99)71206-5

7 January 2021

10.1016/S0033-3182(99)71206-5

Identifiers

DOI

0 references

1 reference